cocaine has been researched along with adamantane in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asin, KE; Nikkel, AL; Wirtshafter, D | 1 |
Crespi, F | 1 |
Chausmer, AL; Katz, JL | 1 |
Crossman, AR; Kobylecki, C; Ravenscroft, P | 1 |
Golozoubova, V; Gotfredsen, CF; Knudsen, LB; Raun, K; Rolin, B; von Voss, P | 1 |
5 other study(ies) available for cocaine and adamantane
Article | Year |
---|---|
Repeated D1 receptor agonist treatment blocks cocaine-induced locomotor activity and c-fos expression.
Topics: Adamantane; Animals; Benzopyrans; Cocaine; Dopamine Agents; Gene Expression; Genes, fos; Immunohistochemistry; Male; Motor Activity; Neostriatum; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1994 |
The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats.
Topics: Adamantane; Alcohol Drinking; Alcoholism; Animals; Benzodiazepinones; Cocaine; Cocaine-Related Disorders; Drinking; Male; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide | 1998 |
Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
Topics: Adamantane; Animals; Benzazepines; Benzopyrans; Cocaine; Discrimination, Psychological; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2002 |
Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.
Topics: Adamantane; Alternative Splicing; Animals; Antiparkinson Agents; Cocaine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Iodine Isotopes; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Messenger; Sympatholytics | 2013 |
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not.
Topics: Adamantane; Animals; Body Composition; Body Weight; Candy; Energy Intake; Energy Metabolism; Glucagon-Like Peptide 1; Hypoglycemic Agents; Liraglutide; Nitriles; Obesity; Pancreas; Pyrrolidines; Rats; Rats, Sprague-Dawley; Vildagliptin | 2007 |